Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**NLR family pyrin domain containing 9 pseudogene 1 (NLRP9P1)**, also known as NOD25, is a processed pseudogene in the NOD-like receptor (NLR) family. Pseudogenes are generally genomic DNA sequences similar to normal genes but usually non-functional; processed pseudogenes are specifically derived from retrotransposed mRNA and typically lack introns or promoter elements. There is no evidence that NLRP9P1 encodes a functional protein, nor is there evidence of its role as a therapeutic target, biomarker, or disease-related molecule. While some pseudogenes can have regulatory functions or be involved in lncRNA-mediated gene regulation, there are no data supporting such a role for NLRP9P1; hence, it should not be considered a molecular target or therapeutic receptor[2][3]. **Note:** - NLRP9P1 is annotated as a pseudogene and not as a functional gene or protein. - There is no evidence for its being a drug target or being involved in biological pathways relevant for therapeutic intervention[3]. - Because NLRP9P1 is a pseudogene, entries relating to drugs, mechanisms, biomarkers, or safety concerns are not applicable. - The name is sometimes confused with closely related genes or pseudogenes in the NLR family, but NLRP9P1 itself is distinct and not known to code for a functional product. If additional or new research emerges indicating a functional role for this specific pseudogene, structured information could be updated accordingly, but as of the current knowledge and gene annotation status, it is not a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NLR family pyrin domain containing 9 pseudogene 1 (NLRP9P1).